Related references
Note: Only part of the references are listed.Cell-programmed nutrient partitioning in the tumour microenvironment
Bradley Reinfeld et al.
NATURE (2021)
Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers
Gabriele Galliverti et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment
Naoki Horikawa et al.
BRITISH JOURNAL OF CANCER (2020)
Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells
Cong Hu et al.
BRITISH JOURNAL OF CANCER (2020)
Immunotherapy for platinum-resistant ovarian cancer
Giorgio Bogani et al.
GYNECOLOGIC ONCOLOGY (2020)
The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer
Naoko Komura et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
Min-Hee Oh et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Metabolism of immune cells in cancer
Robert D. Leone et al.
NATURE REVIEWS CANCER (2020)
Pharmacometabolomics Reveals Irinotecan Mechanism of Action in Cancer Patients
Xun Bao et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment
Yang Zeng et al.
FASEB JOURNAL (2019)
Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas (vol 104, pg 651, 2019)
Laura Remacha et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Competition for nutrients and its role in controlling immune responses
Nidhi Kedia-Mehta et al.
NATURE COMMUNICATIONS (2019)
Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer
Thais Baert et al.
FRONTIERS IN IMMUNOLOGY (2019)
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer
Song Liu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Immunosuppressive Immature Myeloid Cell Generation Is Controlled by Glutamine Metabolism in Human Cancer
Wen-Chao Wu et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum
WonJae Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment
Kelly L. Singel et al.
JCI INSIGHT (2019)
mTOR-mediated glycolysis contributes to the enhanced suppressive function of murine tumor-infiltrating monocytic myeloid-derived suppressor cells
Yuting Deng et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Ovarian cancer therapeutic potential of glutamine depletion based on GS expression
Akiko Furusawa et al.
CARCINOGENESIS (2018)
Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer
Wei Li et al.
CELL METABOLISM (2018)
Metabolic Stress in the Immune Function of T Cells, Macrophages and Dendritic Cells
Charlotte Domblides et al.
CELLS (2018)
Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells
Naoki Horikawa et al.
CLINICAL CANCER RESEARCH (2017)
Cancer metabolism: a therapeutic perspective
Ubaldo E. Martinez-Outschoorn et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Physiological levels of formate activate mitochondrial superoxide/hydrogen peroxide release from mouse liver mitochondria
Adrian Young et al.
FEBS LETTERS (2017)
NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer
J. Brian Szender et al.
GYNECOLOGIC ONCOLOGY (2017)
Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer
Xinxin Zhu et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2017)
Energy metabolic pathways control the fate and function of myeloid immune cells
Amir A. Al-Khami et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis
Shiou-Ling Jian et al.
CELL DEATH & DISEASE (2017)
Myeloid-Derived Suppressor Cells
Dmitry I. Gabrilovich
CANCER IMMUNOLOGY RESEARCH (2017)
Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells
Amir A. Al-Khami et al.
ONCOIMMUNOLOGY (2017)
Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
Sajad Dar et al.
SCIENTIFIC REPORTS (2017)
Myeloid-derived suppressor cells in ovarian cancer: friend or foe?
Monika Walankiewicz et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
The α-ketoglutarate dehydrogenase complex in cancer metabolic plasticity
Renaud Vatrinet et al.
CANCER & METABOLISM (2017)
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden et al.
CELL (2017)
Opportunities in immunotherapy of ovarian cancer
G. Coukos et al.
ANNALS OF ONCOLOGY (2016)
NAD+ metabolism: Bioenergetics, signaling and manipulation for therapy
Yue Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2016)
AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage-Th17 Axis
Ashutosh K. Mangalam et al.
JOURNAL OF IMMUNOLOGY (2016)
The TCA cycle transferase DLST is important for MYC-mediated leukemogenesis
N. M. Anderson et al.
LEUKEMIA (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors
Tingting Wu et al.
SCIENTIFIC REPORTS (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy (vol 16, pg 619, 2016)
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis
Laila M. Poisson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
Junzo Hamanishi et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction
Zaid Al-Wahab et al.
ONCOTARGET (2015)
Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer
Anm Nazmul H. Khan et al.
ONCOTARGET (2015)
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
Fokhrul Hossain et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer
John B. Liao et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with previously treated, recurrent or refractory ovarian cancer: A phase Ib, open-label expansion trial.
Mary L. Disis et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity
Ingunn M. Stromnes et al.
GUT (2014)
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
Diletta Di Mitri et al.
NATURE (2014)
Dietary energy balance modulates ovarian cancer progression and metastasis
Zaid Al-Wahab et al.
ONCOTARGET (2014)
Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer
Jaikumar Duraiswamy et al.
CANCER RESEARCH (2013)
Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2
Tracy X. Cui et al.
IMMUNITY (2013)
Metabolic Pathways in Immune Cell Activation and Quiescence
Erika L. Pearce et al.
IMMUNITY (2013)
Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer
Vincent Lavoue et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Myeloid-Derived Suppressor Cells Modulate Immune Responses Independently of NADPH Oxidase in the Ovarian Tumor Microenvironment in Mice
Heidi E. Godoy et al.
PLOS ONE (2013)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
Minu K. Srivastava et al.
PLOS ONE (2012)
MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
James Finke et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Intraepithelial T Cells and Tumor Proliferation
Sarah F. Adams et al.
CANCER (2009)
Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice
Hanh K. Le et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression
S. Peter Bak et al.
MOLECULAR IMMUNOLOGY (2008)
Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis
Sachie Hiratsuka et al.
NATURE CELL BIOLOGY (2006)
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells
Rongcun Yang et al.
CANCER RESEARCH (2006)
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
P Serafini et al.
SEMINARS IN CANCER BIOLOGY (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A
JR Conejo-Garcia et al.
NATURE MEDICINE (2004)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
